Skip to main content
. 2019 Sep 11;87(1):137–141. doi: 10.1093/neuros/nyz352

TABLE 3.

Secondary Endpoints for rHEMI+ Patients

Surgical group (n = 50) Nonsurgical group (n = 50) Surgical-nonsurgical
Secondary endpoints Number of events Estimated rate (95% CI) Number of events Estimated rate (95% CI) Difference (95% CI) P value
Any stroke 11 22.4 (10.7, 34.1) 12 26.3 (13.4, 39.2) −3.9 (−21.4, 13.5) .66
Fatal stroke 0 0 1 2.5 (0, 7.3) −2.5 (−7.3, 2.3) .31
Disabling stroke 2 4.0 (0, 9.4) 1 2.5 (0, 7.3) 1.5 (−5.8, 8.8) .68
Deaths 0 0 (0.0, 7.1) 4 8.0 (2.2, 19.2) −8.0 (−28.0, 12.5) .12
Any stroke or death 11 22.4 (10.7, 34.1) 14 32.2 (17.9, 46.6) −9.8 (−28.3, 8.7) .30
Modified Rankin score 0 to 1 29 58.0 (44.3, 71.7) 21 42.0 (28.3, 55.7) 16.0 (−3.4, 35.4) .11
Modified Rankin score 0 to 2 39 78.0 (66.5, 89.5) 42 84.0 (73.8, 94.2) −6.0 (−21.3, 0.3) .44
Modified Barthel scale 19 to 20 39 78.0 (66.5, 89.5) 39 78.0 (66.5, 89.5) 0.0 (−16.2, 20.3) 1.0
Summary SSQoL, mean 3.63 (3.34, 3.92) 3.55 (3.28, 3.81) 0.08 (−0.31, 0.47) .68